Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Upgrades Cinemark Hldgs to Overweight

JP Morgan Upgrades Cinemark Hldgs to Overweight

JP Morgan analyst David Karnovsky upgrades Cinemark Hldgs (NYSE:CNK) from Neutral to Overweight.

byBenzinga Newsdesk

January 12, 2023

1 minute read

JP Morgan analyst David Karnovsky upgrades Cinemark Hldgs (NYSE:CNK) from Neutral to Overweight.

What’s Going With CNS Pharmaceuticals Stock Today

By Vandana Singh

April 20, 3:08 PM

CNS Pharmaceuticals Inc (NASDAQ: CNSP) shares opened almost 21% higher at $2.14 on Thursday and gained 70% to reach $3.02 at 1:35 p.m. EST. Although there's no news to justify the huge spike.

CNSP

StoneCo Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

By Avi Kapoor

May 13, 9:33 AM

StoneCo Ltd. (NASDAQ:STNE) is set to release earnings results for its first quarter after the closing bell on…

STNE

Jacobs Solutions Spins Off Its Government Services Business Units, Expects $1B Cash Proceeds

By Lekha Gupta

November 21, 7:04 AM

Jacobs Solutions Inc (NYSE: J) disclosed a definitive deal to spin off and combine its Critical Mission Solutions (CMS) and Cyber & Intelligence government

Stifel Maintains Buy on Microsoft, Lowers Price Target to $290

By Benzinga Newsdesk

October 26, 7:20 AM

Stifel analyst Brad Reback maintains Microsoft (NASDAQ:MSFT) with a Buy and lowers the price target from $300 to $290.

MSFT

JP Morgan Upgrades Cinemark Hldgs to Overweight

Related Posts

What’s Going With CNS Pharmaceuticals Stock Today

StoneCo Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Jacobs Solutions Spins Off Its Government Services Business Units, Expects $1B Cash Proceeds

Stifel Maintains Buy on Microsoft, Lowers Price Target to $290